Back
ESC Premium Access

Comparing long term outcomes of anti-arrhythmic therapy and catheter ablation in arrhythmogenic cardiomyopathy patients with ventricular arrhythmias

Session: Poster Session 3 - Ventricular arrhythmias and SCD. Epidemiology, prognosis, outcome
Topic: Epidemiology, Prognosis, Outcome
Speaker: Associate Professor M. Casella (Ancona, IT)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Michela Casella

Marche Polytechnic University of Ancona, Ancona (Italy)
1 follower

8 more presentations in this session

Clinical scores can infer risk of VT induction in Chagas disease patients

Speaker: Doctor B. VALDIGEM (Sao Paulo, BR)

Access
Abstract
Slides
Like
Thumbnail

Prognosis of Japanese non-ischemic cardiomyopathy patients with an Implantable cardioverter-defibrillator for primary prophylaxis - cardiac sarcoidosis versus hypertrophic cardiomyopathy versus dilate

Speaker: Doctor M. Nakano (Chiba, JP)

Access
Abstract
Like
Thumbnail

A newly developed termination of resuscitation rule in the field for refractory out-of-hospital cardiac arrests in the Japanese aging society

Speaker: Professor Y. Goto (Kanazawa, JP)

Access
Abstract
Slides
Like
Thumbnail

Bystander chest compression-only cardiopulmonary resuscitation in children with out-of-hospital cardiac arrest

Speaker: Professor Y. Goto (Kanazawa, JP)

Access
Abstract
Slides
Like
Thumbnail

Obstructive sleep apnea and the risk of sudden cardiac death or ventricular arrhythmias in postinfarct patients

Speaker: Doctor N. Diaconu (Chisinau, MD)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 3 - Ventricular arrhythmias and SCD. Epidemiology, prognosis, outcome

Speakers: Associate Professor M. Casella, Doctor B. VALDIGEM, Doctor M. Nakano, Professor Y. Goto, Professor Y. Goto...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources